Search

RESEARCHER ID M-3378-2014 (María Vallet Regí) ORCID 0000-0002-6104-4889 (María Vallet Regí), Osteoporosis is a worldwide disease with a very high prevalence in humans older than 50. The main clinical consequences are bone fractures, which often lead to patient disability or even death. A number of commercial biomaterials are currently used to treat osteoporotic bone fractures, but most of these have not been specifically designed for that purpose. Many drug- or cell-loaded biomaterials have been proposed in research laboratories, but very few have received approval for commercial use. In order to analyze this scenario and propose alternatives to overcome it, the Spanish and European Network of Excellence for the Prevention and Treatment of Osteoporotic Fractures, ‘‘Ageing’’, was created. This network integrates three communities, e.g. clinicians, materials scientists and industrial advisors, tackling the same problem from three different points of view. Keeping in mind the premise ‘‘living longer, living better’’, this commentary is the result of the thoughts, proposals and conclusions obtained after one year working in the framework of this network., Ministerio de Economia y Competitividad (MINECO), Depto. de Química en Ciencias Farmacéuticas, Fac. de Farmacia, TRUE, pub

Porous titanium alloy Ti6Al4V scaffolds manufactured via electron beam melting (EBM®) reveal broad prospects for applications in bone tissue engineering. However, local inflammation and even implant failure may occur while placing an implant into the body. Thus, the application of drug carriers to the surface of a metallic implant can provide treatment at the inflammation site. In this study, we propose to use polyelectrolyte (PE) microcapsules formed by layer-by-layer (LbL) synthesis loaded with both porous calcium carbonate (CaCO3) microparticles and the anti-inflammatory drug dexamethasone (DEX) to functionalize implant surfaces and achieve controlled drug release. Scanning electron microscopy indicated that the CaCO3 microparticles coated with PE bilayers loaded with DEX had a spherical shape with a diameter of 2.3 ± 0.2 μm and that the entire scaffold surface was evenly coated with the microcapsules. UV spectroscopy showed that LbL synthesis allows the manufacturing of microcapsules with 40% DEX. According to high performance liquid chromatography (HPLC) analysis, 80% of the drug was released within 24 h from the capsules consisting of three bilayers of polystyrene sulfonate (PSS) and poly(allylamine)hydrochloride (PAH). The prepared scaffolds functionalized with CaCO3 microparticles loaded with DEX and coated with PE bilayers showed hydrophilic surface properties with a water contact angle below 5°. Mouse embryonic fibroblast cells were seeded on Ti6Al4V scaffolds with and without LbL surface modification. The surface modification with LbL PE microcapsules with CaCO3 core affected cell morphology in vitro. The results confirmed that DEX had no toxic effect and did not prevent cell adhesion and spreading, thus no cytotoxic effect was observed, which will be further studied in vivo.

An ultrasonic vibration post-treatment procedure was suggested for additively manufactured lattices. The aim of the present research was to investigate mechanical properties and the differences in mechanical behavior and fracture modes of Ti6Al4V scaffolds treated with traditional powder recovery system (PRS) and ultrasound vibration (USV). Scanning electron microscopy (SEM) was used to investigate the strut surface and the fracture surface morphology. X-ray computed tomography (CT) was employed to evaluate the inner structure, strut dimensions, pore size, as well as the surface morphology of additively manufactured porous scaffolds. Uniaxial compression tests were conducted to obtain elastic modulus, compressive ultimate strength and yield stress. Finite element analysis was performed for a body-centered cubic (BCC) element-based model and for CT-based reconstruction data, as well as for a two-zone scaffold model to evaluate stress distribution during elastic deformation. The scaffold with PRS post treatment displayed ductile behavior, while USV treated scaffold displayed fragile behavior. Double barrel formation of PRS treated scaffold was observed during deformation. Finite element analysis for the CT-based reconstruction revealed the strong impact of surface morphology on the stress distribution in comparison with BCC cell model because of partially molten metal particles on the surface of struts, which usually remain unstressed.

This investigation shows that composite structures based on additive manufactured electron beam melted Ti6Al4V scaffolds coated with calcium carbonate particles can be used as a potential biocomposites for bone substitutes. A continuous bioceramic coating of CaCO3 was deposited on additive manufactured titanium alloy under the influence of ultrasound. XRD analysis revealed the formation of a mixture of calcite and vaterite phases. CaCO3 coating led to decreasing roughness of additively manufactured (AM) scaffolds and improved surface hydrophilicity. In vitro assay demonstrated enhanced inorganic bone phase formation on the surface of CaCO3-coated AM scaffolds compared to as-manufactured ones. The short-term adhesion of S. aureus onto sample surface was evaluated by fluorescent microscopy 0, 3, and 72 h after cell seeding. It revealed that the surface modification resulted in the decreased number of bacteria attached to the surface after CaCO3 deposition. The morphology, roughness, solubility and superhydrophilic character of the CaCO3 coated EBM-manufactured Ti6Al4V alloy surface are suggested as factors contributing to preventing S. aureus adhesion. Thus, the developed biocomposites based on additively manufactured Ti6Al4V alloy scaffolds and CaCO3 coating can be successfully used in bone tissue regeneration providing the effective growth of inorganic bone phase and preventing the bacteria adhesion.

In this paper, the results of the surface functionalization of the Ti6Al4V alloy scaffolds with different structures for use as a material for medical implants are presented. Radio frequency magnetron sputtering was used to modify the surface of the porous structures by deposition of the biocompatible hydroxyapatite (HA) coating with the thickness of 86050 nm. The surface morphology, elemental and phase composition of the HA-coated scaffolds were studied. According to energy-dispersive X-ray spectroscopy, the stoichiometric ratio of Ca/P for flat, orthorhombic and cubic scaffolds is 1.65, 1.60, 1.53, respectively, which is close to that of stoichiometric ratio for HA (Ca/P = 1.67). It was revealed that this method of deposition makes it possible to obtain the homogeneous crystalline coating both on the dense sample and in the case of scaffolds of complex geometry with different lattice cell structure.

In this work porous microparticles of calcium carbonate were synthesized with bovine serum albumin - fluorescein isothiocyanate conjugate (BSA-FITC) and dexamethasone, and then used for encapsulation in polymer microcapsules by means of layer-by-layer assembly (LbL). The properties of the obtained microcapsules were characterized by scanning electron microscopy, dynamic light scattering, infrared-, ultraviolet- and visible spectroscopy. According to the performed DLS measurements, an average hydrodynamic diameter ranged from 4 to 8 m and zeta-potential for all types of capsules was determined as -18 and -21 mV. BSA-FITC was encapsulated using this approach yielded a loading efficiency of 49 % protein. This value calculated for dexamethasone was of 38%. The microcapsules filled with an encapsulated drug may find applications in the field of biotechnology, biochemistry, and medicine.